AVITA MEDICAL, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.66 USD | +1.64% |
|
+0.47% | -37.39% |
| Apr. 17 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
| Apr. 11 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Evolution of the average Target Price on AVITA Medical, Inc.
Price target over the last 5 years
History of analyst recommendation changes
789b817a64070cef14cc119439.WW4bpNCUH_YxMPzwkyWHFuIAyC7HBrBbRRdP3h1wrmY.FRcq8aP8WrkceL-mxnPJILRw-WilX-MsIlkhmypEmBcJA2PqteNvl2QJvQ~0a4bec854510bd0565964920508cfdb1
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
13.06
AUD
Average target price
39.74
AUD
Spread / Average Target
+204.17%
High Price Target
61.65
AUD
Spread / Highest target
+371.87%
Low Price Target
32.22
AUD
Spread / Lowest Target
+146.61%
Consensus detail
Consensus revision (last 18 months)
Analysts covering AVITA Medical, Inc.
| Wilsons | |
| BTIG | |
| Piper Sandler | |
| Cantor Fitzgerald |
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
- Stock Market
- Equities
- RCEL Stock
- Consensus AVITA Medical, Inc.
